In Reply
- PMID: 26377534
- PMCID: PMC4577670
- DOI: 10.3238/arztebl.2015.0601c
In Reply
Comment on
-
Severe asthma: definition, diagnosis and treatment.Dtsch Arztebl Int. 2014 Dec 12;111(50):847-55. doi: 10.3238/arztebl.2014.0847. Dtsch Arztebl Int. 2014. PMID: 25585581 Free PMC article. Review.
-
Marginal Effect and Little Clinical Relevance.Dtsch Arztebl Int. 2015 Aug 31;112(35-36):601. doi: 10.3238/arztebl.2015.0601a. Dtsch Arztebl Int. 2015. PMID: 26377532 Free PMC article. No abstract available.
-
Polysomnographic Screening Helpful.Dtsch Arztebl Int. 2015 Aug 31;112(35-36):601. doi: 10.3238/arztebl.2015.0601b. Dtsch Arztebl Int. 2015. PMID: 26377533 Free PMC article. No abstract available.
References
-
- Humbert M, Beasley R, Ayres J, et al. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. Allergy. 2005;60:309–316. - PubMed
-
- Bardelas J, Figliomeni M, Kianifard F, Meng X. A 26-week, randomized, double-blind, placebo-controlled, multicenter study to evaluate the effect of omalizumab on asthma control in patients with persistent allergic asthma. J Asthma. 2012;49:144–152. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical